Literature DB >> 30611931

A meta-analytic perspective on Arcobacter spp. antibiotic resistance.

Susana Ferreira1, Ângelo Luís1, Mónica Oleastro2, Luísa Pereira3, Fernanda C Domingues4.   

Abstract

OBJECTIVES: Over the years, an increased prevalence of resistant strains of Arcobacter has been observed, which may be due to Arcobacter exposure to antibiotics used both in animal production and human medicine. A systematic review was performed with the objective of summarising the results of the rates of antimicrobial resistance of Arcobacter isolates.
METHODS: The systematic review was performed according to PRISMA (Preferred Reported Items for Systematic Reviews and Meta-Analysis) recommendations, followed by meta-analysis.
RESULTS: It was observed that the resistance rate ranged between 69.3-99.2% for penicillins and 30.5-97.4% for cephalosporins. The overall percentage of resistance to fluoroquinolones ranged from 4.3% to 14.0%, with the highest resistance percentage observed for levofloxacin. Resistance rates ranged between 10.7-39.8% for macrolides, 1.8-12.9% for aminoglycosides and 0.8-7.1% for tetracyclines.
CONCLUSIONS: These results show that Arcobacter spp. present resistance to various antibiotics commonly used and advocate further studies of the associated resistance mechanisms.
Copyright © 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Arcobacter; Meta-analysis; Systematic review

Mesh:

Substances:

Year:  2019        PMID: 30611931     DOI: 10.1016/j.jgar.2018.12.018

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  7 in total

1.  Arcobacter Butzleri in an AIDS Patient.

Authors:  Trevor Hwee Yong Tan; Sai Meng Tham; Paul Anatharajah Tambyah
Journal:  Case Rep Infect Dis       Date:  2022-07-06

2.  Prevalence and antimicrobial susceptibility of Arcobacter species in human stool samples derived from out- and inpatients: the prospective German Arcobacter prevalence study Arcopath.

Authors:  Greta Gölz; Markus M Heimesaat; Vanessa Brückner; Ulrike Fiebiger; Ralf Ignatius; Johannes Friesen; Martin Eisenblätter; Marlies Höck; Thomas Alter; Stefan Bereswill
Journal:  Gut Pathog       Date:  2020-04-15       Impact factor: 4.181

3.  Characterization of Arcobacter spp. Isolated from human diarrheal, non-diarrheal and food samples in Thailand.

Authors:  Paksathorn Kietsiri; Chonchanok Muangnapoh; Woradee Lurchachaiwong; Paphavee Lertsethtakarn; Ladaporn Bodhidatta; Orasa Suthienkul; Norman C Waters; Samandra T Demons; Brian A Vesely
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

4.  Prevalence, antimicrobial susceptibility and virulence gene profiles of Arcobacter species isolated from human stool samples, foods of animal origin, ready-to-eat salad mixes and environmental water.

Authors:  Dainius Uljanovas; Greta Gölz; Vanessa Brückner; Audrone Grineviciene; Egle Tamuleviciene; Thomas Alter; Mindaugas Malakauskas
Journal:  Gut Pathog       Date:  2021-12-20       Impact factor: 4.181

5.  Molecular Cut-off Values for Aliarcobacter butzleri Susceptibility Testing.

Authors:  Quentin Jehanne; Lucie Bénéjat; Astrid Ducournau; Emilie Bessède; Philippe Lehours
Journal:  Microbiol Spectr       Date:  2022-07-07

6.  Aliarcobacter butzleri from Water Poultry: Insights into Antimicrobial Resistance, Virulence and Heavy Metal Resistance.

Authors:  Eva Müller; Mostafa Y Abdel-Glil; Helmut Hotzel; Ingrid Hänel; Herbert Tomaso
Journal:  Genes (Basel)       Date:  2020-09-21       Impact factor: 4.096

7.  Occurrence and Antimicrobial Resistance of Arcobacter spp. Recovered from Aquatic Environments.

Authors:  Sonia Sciortino; Pietro Arculeo; Vincenzina Alio; Cinzia Cardamone; Luisa Nicastro; Marco Arculeo; Rosa Alduina; Antonella Costa
Journal:  Antibiotics (Basel)       Date:  2021-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.